CBP-CON-00171
Active
Federal
NOVO NORDISK PHARMACEUTICALS PTY. LIMITED
Awarded by National Blood Authority
$169.5M
Contract Value
Contract Details
- Reference
- CN3936165
- Jurisdiction
- Federal
- Financial Year
- FY27
- Category
- Healthcare Services(UNSPSC: 85100000)
Description
Imported Plasma and Recombinant Products
Key Dates
- Publish Date
- 16 July 2026
- Effective Date
- 31 Dec 2022
- End Date
- 29 June 2027
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
NOVO NORDISK PHARMACEUTICALS PTY. LIMITED
- ABN
- 40 002 879 996
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 2 times.
Original Contract
Published 9 Feb 2023
$80.3M
Amendment A1
Published 16 July 2026
$115.5M
Amendment A2
Current
Published 16 July 2026
$169.5M